MedWatch

Genmab surpasses 1,000 employees

Biotech firm Genmab has more than doubled its number of employees over a short period of time, bringing them up to over 1,000 staff for the first time.

Photo: Tuala Hjarnø / Genmab / PR

23 years after it was founded, biotech firm Genmab has reached a milestone most can only aspire to.

Thanks to the success of blood cancer drug Darzalex, Genmab has been growing, and in July, the firm surpassed 1,000 employees, it reports on LinkedIn.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP to remove 100 generic medicines from market

Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.

Further reading

Related articles

Latest news

See all jobs